Multiple ventricular septal defects and severe tricuspid regurgitation in an infant - a case report and surgical

Neerod Kumar Jha1,2, Aleksandr Omelchenko3, Ashutosh Goyal4

  • 1Division of Paediatric Cardiac Surgery, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. nk_jha@hotmail.com.

Insights

A minimally invasive perventricular device closure was successfully used to treat an infant with complex ventricular septal defects and severe tricuspid regurgitation. This approach offers a safer alternative for high-risk infants with congenital heart disease.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Minimally Invasive Surgery

Background:

  • Ventricular septal defect (VSD) is the most common congenital heart disease.
  • Multiple VSDs, termed "Swiss Cheese" variant, present complex surgical challenges.
  • Severe tricuspid regurgitation and elevated right ventricular pressure increase surgical risks.

Purpose of the Study:

  • To present a case of complex VSD in an infant with Holt-Oram syndrome.
  • To evaluate a minimally invasive approach for high-risk infants.
  • To demonstrate the feasibility of perventricular device closure.

Main Methods:

  • Case presentation of a six-month-old infant with congestive heart failure and Holt-Oram syndrome.
  • Echocardiography and chest x-ray confirmed diagnosis of multiple VSDs and severe tricuspid regurgitation.
  • Peventricular device closure was chosen due to high risks associated with traditional surgical options.

Main Results:

  • The infant presented with symptoms of congestive heart failure, poor weight gain, and hepatomegaly.
  • Medical management failed, necessitating surgical intervention.
  • Minimally invasive perventricular device closure was performed successfully.

Conclusions:

  • Minimally invasive perventricular device closure is a viable option for infants with complex VSDs, severe tricuspid regurgitation, and genetic disorders.
  • This approach can avoid the risks associated with traditional surgical methods.
  • It offers potentially better outcomes for high-risk pediatric patients.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...